Relevant bibliographies by topics / Tb

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Tb'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tb.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tb"

1

Ficko, C., L. Mangouka, A. Ali Mohammed, C. Géraud, D. Andriamanantena, C. Soler, A. Rasinariu, J. Margery, and C. Rapp. "TB ? Not TB !" La Revue de Médecine Interne 32 (December 2011): S324—S325. http://dx.doi.org/10.1016/j.revmed.2011.10.037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nagaria, Neil, Pankit Vachhani, Sushil Ahlawat, and Hamad Al-Abda. "TB or Not TB." American Journal of Gastroenterology 104 (October 2009): S322—S323. http://dx.doi.org/10.14309/00000434-200910003-00877.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kobylecki, Christopher, Emily Montague, Tom Blanchard, Rekha Siripurapu, and David McKee. "TB or not TB?" Practical Neurology 19, no. 5 (July 10, 2019): 451–55. http://dx.doi.org/10.1136/practneurol-2019-002258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Guo, Ming, Susanna Mak, Dina Reiss, Irving E. Salit, and Maral Ouzounian. "TB or Not TB." Infectious Diseases in Clinical Practice 24, no. 5 (September 2016): e20-e23. http://dx.doi.org/10.1097/ipc.0000000000000347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gunn-Moore, Danièlle. "TB or not TB?" Journal of Small Animal Practice 54, no. 12 (November 28, 2013): 617–19. http://dx.doi.org/10.1111/jsap.12155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Donnelly, Jackie L. "TB or Not TB?" American Journal of Nursing 101, no. 7 (July 2001): 11. http://dx.doi.org/10.1097/00000446-200107000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Heller, Israel, Simon Biner, Aharon Isakov, Yulia Kornitzky, Itzhak Shapira, Silvia Marmor, and Marcel Topilsky. "TB or Not TB." Chest 120, no. 2 (August 2001): 674–78. http://dx.doi.org/10.1378/chest.120.2.674.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hughes, R., T. Felton, M. Munavvar, and J. Howells. "TB or not TB…" Respiratory Medicine Extra 2, no. 1 (January 2006): 4–6. http://dx.doi.org/10.1016/j.rmedx.2005.10.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Speir, William A., and Douglas P. Farman. "TB or not TB." Chest 90, no. 2 (August 1986): 306–7. http://dx.doi.org/10.1378/chest.90.2.306-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Friedberg, Errol C., and Paula L. Fischhaber. "TB or Not TB." Cell 113, no. 2 (April 2003): 139–40. http://dx.doi.org/10.1016/s0092-8674(03)00275-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tb"

1

MacNaughton, April Dawn. "Tuberculosis (TB) storytelling : improving community nursing TB program delivery." Thesis, University of British Columbia, 2015. http://hdl.handle.net/2429/56178.

Full text
Abstract:
This study explores the effectiveness of the traditional First Nations practice of storytelling as a tool in improving Community Health Nurse (CHN) continuing education, regarding tuberculosis (TB) programming in First Nations communities. The first part of this study involves a critical analysis of literature regarding the evolution of Canada’s First Nations policies and health care, and the use of storytelling as a learning tool in Western and First Nations contexts. Informed by critical social justice as a theoretical lens, and decolonising perspectives in health care, the analysis of the literature focuses on (a) shifting factors and societal values shaping the evolution of health care policy and regimes in First Nations health, and (b) the use of storytelling as an educational tool for CHNs working in First Nations communities. The analysis indicates that generations of inequities have resulted in First Nations mistrust of the Western health care system and a widening gap between the health status of First Nations and that of the broader Canadian population. The analysis also reveals that storytelling is an essential component of traditional First Nations education. Finally, the literature shows that there is increasing recognition by current health care policy makers that narrowing the gap in health outcomes requires that First Nations health care programming reflects First Nations input and community needs. The second part of this study evaluates the use of storytelling in CHN TB continuing education. TB continuing education sessions for CHNs included first person accounts by First Nations Elders, as part of the TB Tapestries Project, after which 70 CHNs were invited to provide written feedback. Thematic analysis of this feedback reveals increased appreciation for First Nations traditional storytelling as an important tool in provision of First Nations health care; recognition of the effectiveness of storytelling compared to other teaching methods; and a desire to change future TB programming by including storytelling. Based on the analysis of literature and CHN responses to the TB continuing education sessions, the primary recommendation of this study is to incorporate storytelling into TB education sessions for CHNs and broader health care programming for First Nations communities.
Applied Science, Faculty of
Nursing, School of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
2

Dinic, Lana. "Molecular Diagnosis of TB and MDR-TB in HIV-Coinfection in Nigeria." Thesis, Harvard University, 2012. http://dissertations.umi.com/gsas.harvard:10387.

Full text
Abstract:
Tuberculosis (TB) is the most common opportunistic infection in HIV-infected patients and the emergence of drug-resistant tuberculosis (DR-TB) is a growing problem in resource-limited settings (RLS). TB diagnosis in most RLS still depends on smear microscopy for acid-fast bacilli (AFB) while adequate infrastructure for testing drug sensitivity is unavailable. However, molecular diagnostics that detect Mycobacterium tuberculosis (Mtb) DNA and its genetic markers of drug resistance were recently developed. In this thesis I describe the use of a molecular diagnostic, Genotype MTBDRplus, for characterizing DR-TB and patterns of tuberculosis-like infection in two cities in south-west and north-central Nigeria. I found high rates of DR-TB in Nigerian HIV-infected individuals (9.3% for RIF or INH) with significantly different amounts by location (18.18% in south-west vs. 3.91% in north-central Nigeria, p=0.01). RIF resistance, indicative of MDR-TB, was found in 5.52% treatment-naïve patients, far exceeding the WHO predictions (0-4.3%). Furthermore, RIF resistance was genetically distinct, suggesting location-specific transmission of drug resistance (p=0.04). Genotype MTBDRplus correctly identified the drug-resistant samples compared to sequencing in 96.8% of cases. Mtb was confirmed in 56% of patients and was less likely to be found in patients on ART, while controlling for other relevant demographic characteristics (OR 0.29, P=0.02). Only abnormal respiratory findings on auscultation and the direct sputum smear grade greater than 3/100 were significant predictors of Mtb infection (OR 3.28, P=0.03; OR 6.40, p<0.01 respectively). Concentrated sputum smear was not significantly correlated with Mtb infection, except at the highest grades (>2+). Furthermore, in 49% of samples that were not confirmed for Mtb other actinomycetes were found: atypical Mycobacteria (ATM), Rhodococcus spp., Nocardia spp., Corynebacterium spp. I conclude that concentrated sputum AFB smears may misidentify bacteria as Mtb in a subset of HIV-infected patients. These individuals may have a different, even uncharacterized, actinomycete infection in the respiratory tract. Furthermore, total DR-TB in HIV-infection is high and transmission of DR-TB in HIV-infected patients in Nigeria is higher than estimated by the WHO. Molecular diagnostics are a rapid method for identifying Mtb and monitoring DR-TB, and can guide appropriate treatment decisions for respiratory infections in RLS with a high HIV burden.
APA, Harvard, Vancouver, ISO, and other styles
3

Kajunguri, Damian. "Modelling the impact of TB superinfection on the dynamics of HIV-TB coinfection." Thesis, Stellenbosch : University of Stellenbosch, 2009. http://hdl.handle.net/10019.1/4070.

Full text
Abstract:
Thesis (MSc (Mathematics))--University of Stellenbosch, 2009.
ENGLISH ABSTRACT: In this thesis, a mathematical model describing the interaction between HIV and TB in the presence of TB superinfection is presented. The model takes into account two strains of Mycobacterium tuberculosis (MTB), where one strain is drug-sensitive and the other is resistant to at least one of the first-line anti-tuberculosis drugs. The impact of TB superinfection on the incidence and prevalence of TB in HIV-negative and HIVTB coinfected individuals is evaluated. Various control measures such as condom use, antiretroviral therapy, isoniazid preventive therapy and increased TB detection are studied using this model. Numerical results show that TB superinfection increases the prevalence and incidence of TB and its impact is more in HIV-negative than HIV-TB coinfected individuals. The results also show that TB superinfection promotes strain coexistence and increases the associated HIV mortality. Increased condom use was found to have a high positive impact towards the control of the two epidemics. Antiretroviral therapy decreases the TB notification rate and its impact on HIV prevalence increases with the coverage and efficacy. Isoniazid preventive therapy has a clear effect on the TB prevalence. Finally, increased TB detection was found to have a less impact on the TB incidence in HIV-TB coinfected individuals
AFRIKAANSE OPSOMMING: In hierdie verhandeling word ´n wiskundige model vir die interaksie tussen MIV en TB, in ´n situasie met TB superinfeksie voorgelˆe. Die model neem twee variante van TB in ag. Een van die variante is sensitief vir MTB behandeling, terwyl die ander weerstandig is vir ten minste een van die eerste-linie TB behandenings. Die impak van TB superinfeksie op die insidensie and prevalensie van TB in MIV negatiewe en MIV-TB ko-ge˜ınfekteerde individu word ondersoek. Veskeie beheer maatreels soos kondoom gebruik, anti-retrovirale behandeling (vir MIV) en isonazid voorkomende behandeling en verhoodge TB deteksie (vir TB) word ondersoek. Numeriese resultate wys TB superinfeksie verhoog die prevalense en insidensie van TB en dat dit ´n groter bydrae maak by MIV negatief as by MIV-TB ko-geinfekteerde individu. Die resultate wys veder TB superinfeksie promofeer variant kohabitasie en verhoog MIV verwante mortalitieit. Verhoogde kondoom gebruik is gevind om ´n positiewe bydrae te maak tot die beheer van beide epidemies. Anti-retrovirale terapie verlaag die TB aanmeldings koers en die impak van ART verhoog saam met ´n verhoging in die dekking en effektiwiteit daarvan. Voorkomende behandeling het ´n beduidende impak op TB prevalensie. Ons vind dat TB deteksie ´n beperkte impak maak op TB insidensie by MIV-TB ko-geinfekteerde individu
APA, Harvard, Vancouver, ISO, and other styles
4

FRANCISCO, Samuel Nuno Furtado da Conceição. "Aplicação de sistemas moleculares na detecção rápida de MDR-TB e XDR-TB." Master's thesis, Instituto de Higiene e Medicina Tropical, 2011. http://hdl.handle.net/10362/5625.

Full text
Abstract:
Mycobacterium tuberculosis é o agente etiológico da tuberculose em humanos e segundo as estimativas da Organização Mundial da Saúde, um terço da população mundial está infectada com esta bactéria, calculando-se que no ano de 2008 aproximadamente 9,4 milhões de pessoas contraíram tuberculose activa. Associada a esta tendência, encontra-se o aumento alarmante da incidência de tuberculose resistente aos antibióticos, mais propriamente da tuberculose multirresistente e extensivamente resistente. Nesta Dissertação estudaram-se três sistemas de detecção molecular (INNO-LiPA Rif. TB, Innogenetics, Ghent, Bélgica, MTBDRplus e MTBDRsl, GenoType, GmbH, Nehren, Alemanha), que permitem detectar o complexo M. tuberculosis e as mutações mais comuns associadas à resistência aos antibióticos de primeira e segunda linha. Para o efeito, na primeira parte do trabalho os três sistemas em estudo foram testados em 21 isolados clínicos pertencentes à colecção do Laboratório de Micobactérias do Instituto de Higiene e Medicina Tropical (IHMT, UNL), com o propósito de avaliar a sua capacidade para identificar o complexo M. tuberculosis e detectar mutações ligadas à resistência aos fármacos de primeira e segunda linha. Na segunda parte do trabalho, os sistemas INNO-LiPA Rif. TB e MTBDRplus foram testados em 33 amostras respiratórias com baciloscopia positiva, com o propósito de aferir a “performance” destes sistemas para a detecção directa de tuberculose multirresistente em amostras respiratórias. Na primeira parte do trabalho os três sistemas em estudo apresentaram elevada sensibilidade na identificação do complexo M. tuberculosis em culturas, bem como na detecção de mutações ligadas à resistência aos antibióticos de primeira linha, com excepção do etambutol. No que diz respeito à detecção da resistência aos antibióticos de segunda linha, não foi possível calcular os valores de sensibilidade e especificidade. Na segunda parte do trabalho, o INNO-LiPA Rif. TB demonstrou ser o sistema mais robusto para a análise directa de amostras respiratórias com baciloscopia positiva, para um diagnóstico precoce de tuberculose e detecção de resistência à rifampicina. O MTBDRplus não se mostrou uma alternativa viável ao INNO-LiPA Rif. TB, pois apresentou baixa sensibilidade para a identificação do complexo M. tuberculosis e vários problemas no passo de amplificação. O MTBDRsl não foi testado, por não ter sido detectada nenhuma amostra multirresistente.
Mycobacterium tuberculosis is the etiologic agent of tuberculosis in humans and, according to the World Health Organization, one-third of the world’s population is infects with this bacteria, with an estimated 9.4 million incident cases of tuberculosis globally in 2008. Associated with this alarming trend is a frightening increase in the incidence of M. tuberculosis resistant to antibiotics, more specifically multidrug-resistant tuberculosis and extremely drug-resistant tuberculosis. In this Thesis, we studied three molecular detection systems (INNO-LiPA Rif. TB, Innogenetics, MTBDRplus and MTBDRsl, GenoType), which allow the molecular identification of the M. tuberculosis complex and the detection of mutations most often associated with antibiotic resistance. In the first phase of the work the three systems were tested in 21 clinical isolates belonging to the collection of the Mycobacteria Laboratory of IHMT, UNL, with the aim to assess their ability for identifying the M. tuberculosis complex and to detect mutations related to the resistance to first and second line antibiotics. In the second stage of the study, the INNO-LiPA Rif. TB and the MTBDRplus were tested in acid-fast positive respiratory specimens, to assess their performance to detect directly M. tuberculosis and mutations related to rifampicin resistance in these specimens. In the first part of the work the three systems showed high sensitivity for the identification of the M. tuberculosis complex and for detection of resistance to first line antibiotics, except for ethambutol. Regarding the detection of resistance in second line antibiotics, we could not calculate the sensitivity and specificity. In the second part of the work the INNO-LiPA Rif. TB assay proved to be the system of choice for use directly in acid-fast positive respiratory specimens in the early diagnosis of tuberculosis and the detection of rifampicin resistance. The MTBDRplus was not a good alternative to the INNO-LiPA Rif. TB due to its low sensitivity in the identification of the M. tuberculosis complex and the occurrence of several problems in the amplification step. The MTBDRsl was not used because no multidrug resistant samples were detected.
APA, Harvard, Vancouver, ISO, and other styles
5

Sillah, Dolly Jackson. "Early changes in T cell responses in TB patients during chemotherapy for TB." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.536815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bistline, Kathryn Lou. "Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme." Doctoral thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/28441.

Full text
Abstract:
South Africa has one of the world’s highest burdens of TB, HIV/TB co-infection, and drug-resistant TB. Second-line TB treatment is less effective, more expensive, and more toxic than treatment for drug-sensitive TB. Nearly 1 in every 5 persons who starts treatment for drug-resistant TB in South Africa will die; 1 in every 3 persons who survives treatments experiences permanent, profound hearing loss. For decades there was little progress in TB research, however, and so treatment with old regimens continued despite safety concerns. In 2012 the US and European regulatory authorities approved a new drug, bedaquiline, but only for treatment in cases with no other options. In 2015, the South African Medicines Control Council approved bedaquiline for drug-resistant TB, but only a limited number of doses were approved in the 2016/2017 annual budget and the focus, again, was only for the patients who had no other options. In order to inform policy makers in planning and budgeting for drug-resistant TB treatment, the aim of this thesis was to determine whether the simple calculation that bedaquiline was too expensive relative to standard regimens using kanamycin was too simple. Particularly, given the high burden of adverse drug reactions (ADR) associated with kanamycin, would the inclusion of the cost and burden of ADR affect the incremental cost effectiveness ratio of a new treatment regimen where bedaquiline replaces kanamycin? Analysis of the national drug-resistant TB case register showed that mortality during second-line treatment was early, primarily in the first 6 months of treatment, even when patients do not have extensive drug resistance. HIV-positive patients not on anti-retroviral therapy (ART) at initiation of drug-resistant TB treatment have the highest risk of mortality. The high early mortality is a real risk that clinicians have to balance when deciding to initiate ART and effective second-line TB treatment both as quickly as possible. Daily injections coupled with taking more than 10 pills each day are a heavy burden for patient compliance, but also pose concerns in terms of overlapping and compounding toxicities; this burden was confirmed through a meta-analysis of the pooled frequency of adverse events among cohorts with at least 25% of the patients HIV-positive. A competing risk analysis of a cohort of drug-resistant TB patients from Johannesburg – addressing the reality that patients may not have experienced an ADR because they died rather than because they were at lower risk – indicated that HIV-infected patients who are not yet stable on ART and second-line TB treatment are at the highest risk of ADR. A Markov model built and parameterized using the data from the South African national TB programme indicates that bedaquiline for all drug-resistant TB led to a small gain in effectiveness at a cost that was under the costs of the drug itself, due to savings from daily injection visits. While cost-effective, it was not clear that South African policy makers needed to move beyond the offer of bedaquiline for patients with extensive drug resistance. However, the calculation, and the decision point, were different once the costs and disability associated with ADRs was included in the analysis. Bedaquiline-based regimens offer a cost-saving and more effective alternative to an injection-based regimen for drug-resistant TB patients treated in the public sector in South Africa.
APA, Harvard, Vancouver, ISO, and other styles
7

Denis, Marie F. "Extrapulmonary tuberculosis in HIV-positive and HIV-negative children in Haiti : a hospital-based Investigation." [Tampa, Fla] : University of South Florida, 2005. http://purl.fcla.edu/usf/dc/et/SFE0001404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brent, Andrew. "The Kilifi Improving Diagnosis and Surveillance of Childhood TB Study : the KIDS TB Study." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/14399.

Full text
Abstract:
Improving diagnosis and surveillance of childhood TB are key research priorities. We established intensified case finding and state of the art TB diagnostics to investigate the performance of clinical and laboratory tools for childhood TB diagnosis at 2 hospitals in Kenya. We estimated the community incidence of childhood TB using a continuous demographic surveillance survey and detailed surveillance sensitivity analysis. 2041 children were investigated for suspected TB. 70 (3.4%) had bacteriologically confirmed TB, 63 (3.1%) had clinically highly probable TB, and a further 144 (7.1%) were treated for TB based on their clinical presenting features. 107/133 (80%) confirmed/highly probable TB (CHPTB) cases had pulmonary TB. CHPTB was associated with HIV infection (OR 2.1, 95% CI 1.3-3.2), malnutrition (1.5, 1.0-2.1) and close TB contact (5.7, 3.8-8.5). The population attributable fraction of a known close TB contact was 38.8-52.5%. The estimated community incidence of CHPTB locally and nationally was 46 and 83 per 100,000 per year, respectively. The performance of published clinical diagnostic tools varied widely, but the accuracy of all was limited. We derived and independently validated a simple KIDS TB Score that ruled out TB in 2/3 suspects with 98.8% negative predictive value, stratifying other children into groups of increasing risk. Bacteriological yield was highest for the Mycobacterial Growth Inhibitor Tube (MGIT) method (sensitivity 34%, 29-39%, among CHPTB patient samples), and lower for the Microscopic Observation Drug Susceptibility (MODS) assay (30%, 24-35%). The study provides the first comprehensive description from the region of the clinical spectrum of childhood TB, and the only prospective incidence estimates. It suggests up to half of all cases are potentially preventable by implementing current recommendations for isoniazid chemoprophylaxis. The diagnostic performance of clinical and laboratory methods should inform development of future clinical guidelines and laboratory capacity.
APA, Harvard, Vancouver, ISO, and other styles
9

Wasuna, Antonina. "Repositioning fusidic acid for tuberculosis: semi-synthesis of analogues and impact of mycobacterial biotransformation on antibiotic activity." Doctoral thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/28154.

Full text
Abstract:
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is one of the leading causes of death globally, especially in low and middle-income countries. TB is primarily a curable disease, with chemotherapy predicated on a combination of four drugs. The increase in multiple forms of drug-resistant TB is a major cause for concern, underpinning the importance of a continuous pipeline of new anti-TB agents. Drug repositioning - that is, the optimization of existing drugs for new therapeutic indications - has shown promise in expanding the therapeutic options for TB chemotherapy. Fusidic acid (FA), a natural product-derived antibiotic, has modest in vitro antimycobacterial activity. Through a multi-disciplinary approach combining aspects of chemistry and biology, this study investigated the pharmacological and physicochemical properties of FA that might be exploited for optimization of FA as a lead compound for TB drug discovery. FA is a weak carboxylic acid, and it was hypothesised that the carboxylic acid moiety limits its permeation of the complex mycobacterial cell wall. Therefore, this study aimed to identify novel FA analogues with improved permeation properties and designed to act as potential prodrugs. By modifying the C-3 hydroxyl and the carboxylic acid moiety, alkyl and aminoquinoline derivatives were covalently fused to FA through ester and amide coupling reactions to generate hybrids and/or potential prodrugs.
APA, Harvard, Vancouver, ISO, and other styles
10

de, Jager Veronique Rejean. "Trends in the presenting clinical profile of patients with pulmonary tuberculosis in the Western Cape, 1991 - 2009." University of the Western Cape, 2017. http://hdl.handle.net/11394/6455.

Full text
Abstract:
Magister Public Health - MPH (Public Health)
Over the past two decades, despite a growing tuberculosis (TB) epidemic, the South African health system and National TB Programme (NTP) have taken significant steps to ensure improved clinical awareness, early diagnosis, prompt treatment initiation and follow-up of treatment outcomes in cases of TB. The effects of these programmatic measures over time on changes in the severity of disease and presenting clinical profile of patients with pulmonary TB have not been studied. Doing so may provide another window on the impact of TB control initiatives in South Africa.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tb"

1

Carter, Michael. HIV & TB. London: NAM, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zimbabwe. Ministry of Health and Child Care. AIDS & TB Unit. National TB guidelines. 4th ed. Republic of Zimbabwe: AIDS and TB Unit, Ministry of Health and Child Welfare, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

TB. Irwin, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Certo. Supervision TB. Irwin, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Megginson. Tb Management. Not Avail, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aczel. Statistics TB. McGraw-Hill Education, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mescon. Tb Management. 3rd ed. Not Avail, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bateman. Mgmt TB. Irwin, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bateman. Mgmt TB. McGraw-Hill Education, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gatewood. Mgt TB. McGraw-Hill Education, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tb"

1

Cioffi, William G., Michael D. Connolly, Charles A. Adams, Mechem C. Crawford, Aaron Richman, William H. Shoff, Catherine T. Shoff, et al. "Tuberculosis (TB)." In Encyclopedia of Intensive Care Medicine, 2337. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cotton, S. A. "Tb Terbium." In Organometallic Compounds of the Lanthanides, Actinides and Early Transition Metals, 171–72. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4899-7164-7_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Macintyre, J. E. "Tb Terbium." In Dictionary of Organometallic Compounds, 349. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4615-6847-6_51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

García-Elorriaga, Guadalupe, and Guillermo del Rey-Pineda. "TB Infection." In Practical and Laboratory Diagnosis of Tuberculosis, 55–72. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-20478-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Macintyre, J. E., F. M. Daniel, D. J. Cardin, S. A. Cotton, R. J. Cross, A. G. Davies, R. S. Edmundson, et al. "Tb Terbium." In Dictionary of Organometallic Compounds, 215. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4757-4966-3_56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nayak, Rajendra Prasad, Srinivas Sethi, and Sourav Kumar Bhoi. "Tb-Pad." In Cognitive Computing Using Green Technologies, 133–45. First edition. | Boca Raton, FL : CRC Press/Taylor & Francis Group, LLC, 2021. | Series: Green energy and technology : Concepts and applications: CRC Press, 2021. http://dx.doi.org/10.1201/9781003121619-8-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Theisler, Charles. "Tuberculosis (TB)." In Adjuvant Medical Care, 338–39. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Carow-Watamura, U., D. V. Louzguine, and A. Takeuchi. "Cu-Mg-Tb." In Physical Properties of Ternary Amorphous Alloys. Part 3: Systems from Cr-Fe-P to Si-W-Zr, 87–89. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-14133-1_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Selgelid, Michael J., Paul M. Kelly, and Adrian Sleigh. "TB Matters More." In International Public Health Policy and Ethics, 233–47. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-8617-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Müringer, Alfred. "Die Bestimmungen (TB)." In Die Tarifbestimmungen für die Kraftfahrtversicherung (TB), 37–325. Wiesbaden: Gabler Verlag, 2005. http://dx.doi.org/10.1007/978-3-322-90412-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tb"

1

Patel, M., and P. Teckchandani. "TB or Not TB." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kahanowitch, R., D. Cleves, N. Dham, M. Carillo, and A. C. Koumbourlis. "TB or Not TB." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nowosiwsky, Andry, Nicholas Burke, John D. Moore, and Gary R. Krieger. "TB or Not TB: Development of an Integrated Occupational and Community Health TB Surveillance Program." In SPE International Conference and Exhibition on Health, Safety, Security, Environment, and Social Responsibility. Society of Petroleum Engineers, 2016. http://dx.doi.org/10.2118/179413-ms.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Haq, Aqsa, Amudeep Sandhu, Thomas Swaine, Devan Vaghela, Matthew Burman, Heinke Kunst, Jonathan Lambourne, Mathina Darmalingham, Simon Tiberi, and Jessica Potter. "Tb or not Tb; that is the paradoxical reaction." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cheema, A., S. Assaf, and E. S. Guy. "TB or Not TB but NTM - Mycobacterial Double Whammy." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lu, Junqiang, Lei Chen, Congzhang Qiu, Weiyan Yang, Feifei Zhang, and Ruifang Yang. "Preparation and Properties Investigation of Neutron Absorber Material Mo-Tb-Dy and Y-Tb-Dy Alloys." In 2017 25th International Conference on Nuclear Engineering. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/icone25-66747.

Full text
Abstract:
Control rods with low worth absorber materials may provide a mechanical means of making relatively small adjustments in core reactivity. Mo-Tb-Dy and Y-Tb-Dy alloys were developed to obtain appropriate nuclear performance for low worth absorber material. The two alloys were prepared by powder metallurgy technology and vacuum melting technology individually. To clarify the effects of Mo and Y diluents, Tb-Dy was also prepared to be compared. The microstructures were analyzed by X-ray diffraction (XRD), Scanning Electron Microscope (SEM) and Transmission Electron Microscopy (TEM). The experiment results showed that homogeneous microstructures were obtained. Out-pile properties, including mechanical properties, thermal conductivities, thermal expansion, corrosion resistance properties and ion irradiation properties were measured and analyzed. Y-Tb-Dy has similar properties with Tb-Dy. With temperature increasing, yield strengths of Tb-Dy and Y-Tb-Dy decreases largely while Mo-Tb-Dy decreases slightly. Thermal conductivities of Mo-Tb-Dy were four times more than Tb-Dy and Y-Tb-Dy. Mo element significantly increases thermal conductivity. Tb-Dy and Y-Tb-Dy showed severe corrosion and became powders in 280°C/10MPa de-ionized water while Mo-Tb-Dy had very slow corrosion rate. All three alloys were irradiated at 400∼700°C for 25 displacement per atom (dpa). No voids was observed for Tb-Dy and Y-Tb-Dy. Void diameter increases and its density decreases with temperature increasing for Mo-Tb-Dy. Maximum irradiation swelling rate with 0.5% was observed at 500°C. Irradiation swelling significantly decreased with increasing irradiation temperature.
APA, Harvard, Vancouver, ISO, and other styles
7

de Koning, Constance. "TB management update." In Nordic Lung Congress 2022, edited by Vibeke Backer. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/5222e363.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Khalid, Salema, and Sarah Bartram. "AB0632B TB OR NOT TB, THAT IS THE VASCULITIC QUESTION." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8260.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Liu, Luju, and Yusen Wu. "Global dynamics of a TB transmission model with TB defaulters." In 2013 International Conference on Advanced Mechatronic Systems (ICAMechS). IEEE, 2013. http://dx.doi.org/10.1109/icamechs.2013.6681831.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Frost, Geoffrey T., Grant Theron, and Thomas Niesler. "TB or not TB? Acoustic cough analysis for tuberculosis classification." In Interspeech 2022. ISCA: ISCA, 2022. http://dx.doi.org/10.21437/interspeech.2022-383.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Tb"

1

Hersey, Anne. ChEMBL Deposited Data Set - GSK TB Set. EMBL-EBI, January 2013. http://dx.doi.org/10.6019/chembl2095176.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hersey, Anne. ChEMBL Deposited Data Set - Malaria Box TB screen. EMBL-EBI, January 2013. http://dx.doi.org/10.6019/chembl2094260.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tartarelli, G. F. Direct Measurement of |V{sub tb}| at CDF. Office of Scientific and Technical Information (OSTI), December 1997. http://dx.doi.org/10.2172/598756.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wentz, Frank. The Estimation of TOA TB From Aquarius Observations. Remote Sensing Systems, January 2006. http://dx.doi.org/10.56236/rss-ak.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Parks, E. J., G. J. Olson, and F. E. Brinckman. Environmental factors and mechanisms controlling degradation of Tb(III) chelates: development of effective new Tb phosphors for postage stamp use. Gaithersburg, MD: National Bureau of Standards, January 1985. http://dx.doi.org/10.6028/nbs.ir.85-3132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Parks, E. J., R, A. Faltynek, and F. E. Brinckman. Environmental factors and mechanisms controlling degradation of Tb(III) chelates: development of effective new Tb phosphors for postage stamp use. Gaithersburg, MD: National Bureau of Standards, January 1987. http://dx.doi.org/10.6028/nbs.ir.87-3533.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tartarelli, Giuseppe Francesco. Measurement of the CKM element V tb at CDF. Office of Scientific and Technical Information (OSTI), January 1996. http://dx.doi.org/10.2172/1421749.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, January 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Full text
Abstract:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et al., 2018). Mozambique has one of the highest global incidence of malaria-HIV and TB-HIV co-infection, which raises the likelihood of poor clinical outcomes (Moon et al., 2019; USAID, 2018). This rapid literature review highlights key aspects of the epidemiology of malaria, HIV and TB in Mozambique and challenges in prevention, detection and treatment; and surveys select interventions that seek to address these challenges. This is part of a series of reports looking into Epidemiology of Malaria, human immune deficiency virus (HIV) and tuberculosis (TB) across a set of African Nations.
APA, Harvard, Vancouver, ISO, and other styles
9

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, January 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Full text
Abstract:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et al., 2018). Mozambique has one of the highest global incidence of malaria-HIV and TB-HIV co-infection, which raises the likelihood of poor clinical outcomes (Moon et al., 2019; USAID, 2018). This rapid literature review highlights key aspects of the epidemiology of malaria, HIV and TB in Mozambique and challenges in prevention, detection and treatment; and surveys select interventions that seek to address these challenges. This is part of a series of reports looking into Epidemiology of Malaria, human immune deficiency virus (HIV) and tuberculosis (TB) across a set of African Nations.
APA, Harvard, Vancouver, ISO, and other styles
10

Haider, Huma. Malaria, HIV and TB in Mozambique: Epidemiology, Disease Control and Interventions. Institute of Development Studies, January 2022. http://dx.doi.org/10.19088/k4d.2022.035.

Full text
Abstract:
Malaria, HIV and tuberculosis (TB) are significant public health concerns in Mozambique. Malaria was the fourth leading cause of death in the country in 2019, accounting for 42% of deaths among children under 5 years of age (Mugabe et al., 2021; USAID, 2018). Mozambique is among the top eight countries with the highest HIV prevalence; with the second highest mother-to-child transmission (MTCT) rate in the world (Fuente-Soro et al., 2021; Nacarapa et al., 2021). The incidence of TB is rising, with pediatric TB cases almost tripling in recent years (WHO, 2020b; Nguenha et al., 2018; Orlando et al., 2018). Mozambique has one of the highest global incidence of malaria-HIV and TB-HIV co-infection, which raises the likelihood of poor clinical outcomes (Moon et al., 2019; USAID, 2018). This rapid literature review highlights key aspects of the epidemiology of malaria, HIV and TB in Mozambique and challenges in prevention, detection and treatment; and surveys select interventions that seek to address these challenges. This is part of a series of reports looking into Epidemiology of Malaria, human immune deficiency virus (HIV) and tuberculosis (TB) across a set of African Nations.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tb' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography